NASDAQ: SYSo Young International Inc Stock
$1.13-0.01 (-0.88%)
Updated Sep 27, 2023
SY Price
$1.13
Fair Value Price
$7.60
Market Cap
$111.31M
52 Week Low
$0.50
52 Week High
$3.07
P/E
45.2x
P/B
0.33x
P/S
0.98x
PEG
N/A
Dividend Yield
N/A
Revenue
$190.10M
Earnings
$2.63M
Gross Margin
67.4%
Operating Margin
-0.36%
Profit Margin
1.4%
Debt to Equity
0.26
Operating Cash Flow
N/A
Beta
0.91
Next Earnings
Nov 16, 2023
Ex-Dividend
N/A
Next Dividend
N/A
SY Overview
So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments in the People's Republic of China and internationally. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment; equipment production, sales, and agency services; and micro finance services. As of December 31, 2021, it had approximately 8,400 medical aesthetic service providers and 5,000 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SY ($1.13) is undervalued by 85.13% relative to our estimate of its Fair Value price of $7.60 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SY ($1.13) is significantly undervalued by 85.13% relative to our estimate of its Fair Value price of $7.60 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SY was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SY due diligence checks available for Premium users.
Be the first to know about important SY news, forecast changes, insider trades & much more!
SY News
Valuation
SY fair value
Fair Value of SY stock based on Discounted Cash Flow (DCF)
Price
$1.13
Fair Value
$7.60
Undervalued by
85.13%
SY ($1.13) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SY ($1.13) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SY was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
45.2x
Industry
56.15x
Market
13.45x
SY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.33x
Industry
3.13x
SY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SY's financial health
Profit margin
Revenue
$56.9M
Net Income
-$356.1k
Profit Margin
-0.6%
SY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$437.0M
Liabilities
$86.2M
Debt to equity
0.26
SY's short-term assets ($264.55M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SY's short-term assets ($264.55M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
SY vs Health Information Service Stocks
So Young International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.